Position in VYGR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$13,510,000
-$2,210,000 QoQ
Shares Held
3,500,000
-12.5% QoQ
Ownership
5.79%
of shares outstanding
% of Portfolio
0.45%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VYGR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ARMISTICE CAPITAL, LLC holds $1,383,943,824 across 55 Biotechnology names. VYGR ranks #27 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TVTX |
Travere Therapeutics, Inc.
|
4,897,417 | $145,502,259 | |
| 2 | PTCT |
Ptc Therapeutics, Inc.
|
2,074,449 | $141,332,210 | |
| 3 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
264,583 | $138,501,263 | |
| 4 | AGIO |
Agios Pharmaceuticals, Inc.
|
2,716,000 | $91,882,280 | |
| 5 | IMVT |
Immunovant, Inc.
|
3,564,916 | $88,552,513 | |
| 6 | INCY |
Incyte Corp
|
656,817 | $61,819,616 | |
| 7 | DYN |
Dyne Therapeutics, Inc.
|
3,175,110 | $57,564,744 | |
| 8 | CYTK |
Cytokinetics Inc
|
764,538 | $50,390,699 |
All Filings in VYGR
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,510,000 | 3,500,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $15,720,000 | 4,000,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $19,614,000 | 4,200,000 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $14,928,000 | 4,800,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $18,373,680 | 5,436,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $30,595,320 | 5,396,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $30,420,000 | 5,200,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $41,132,000 | 5,200,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $43,496,320 | 4,672,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $35,751,840 | 4,236,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $32,379,500 | 4,178,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $41,494,800 | 3,624,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $27,170,040 | 3,524,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $20,715,600 | 3,396,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $20,104,320 | 3,396,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $15,153,240 | 2,564,000 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $15,240,000 | 2,000,000 | Shares | Sole | 2022-05-16 | |
| 2021-09-30 | $9,773,080 | 3,716,000 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $15,347,080 | 3,716,000 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $17,502,360 | 3,716,000 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $24,252,800 | 3,392,000 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $28,809,000 | 2,700,000 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $26,224,360 | 2,078,000 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $20,459,400 | 2,236,000 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||